Tag: endovascular-BCI

3 articles

Market Moves

Synchron's long road to reaching the brain through a blood vessel

Synchron began with a cold email from Tom Oxley to DARPA in 2011 and a US$1 million offer to build a brain implant that travels through the veins. Fifteen years on it has put its first-generation Stentrode into ten people in Melbourne and the United States, raised US$345 million, connected its implant to Apple devices, Amazon's Alexa and OpenAI's models, and started trials of a fully wireless second-generation device. Enrolment in its US and Australian trials is paused while Synchron upgrades the hardware, and the company says it will restart once that work is finished.

Nov 13

Industry News

Synchron pauses enrolment in its Stentrode trials over a problem with the implant's lead

Synchron has paused enrolment in trials of its updated, fully wireless Stentrode after a performance problem with the lead, the cable that carries signals from the Stentrode to the implanted electronics. The company says it chose to pause on its own and that no device-related safety issues have been found, and it is upgrading the whole system before restarting. WIRED reported that Synchron is also cutting jobs and scaling back in New York while building a San Diego team for a new device. Separately, the registry entry for its Canadian study lists it as terminated in September for insufficient recruitment.

Nov 13

Industry News

Chinese endovascular BCI can be positioned in 10 minutes, Xuanwu Hospital surgeon says

Duan Wanru of Xuanwu Hospital in Beijing said an experienced surgeon can position a Chinese endovascular brain-computer interface in as little as 10 minutes. StairMed unveiled a separate endovascular research program in December 2025 with the Chinese Academy of Sciences, currently in sheep testing. Nankai University completed China's first interventional human BCI in June 2025. Three Chinese endovascular BCI programs are now on the public record.

Aug 10